New spinal implants under study for chronic back pain relief
NCT ID NCT06342765
First seen Mar 25, 2026 · Last updated May 15, 2026 · Updated 8 times
Summary
This study looks at three types of SpineVision spinal implants (Lumis, Plus, and Ulis) used to treat degenerative disc disease, a condition where spinal discs wear down. Researchers will track 330 adults for up to 2 years after surgery to see how safe the implants are and how well they relieve pain and improve disability. The goal is to confirm these devices work as intended as part of standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTERVERTEBRAL DISC DEGENERATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinique du dos Bordeaux-Terrefort
RECRUITINGBruges, 33520, France
Contact Email: •••••@•••••
-
DOSCEA Pôle Rachis
RECRUITINGBayonne, 64100, France
Contact Email: •••••@•••••
-
Orthéo Neurochirurgie
RECRUITINGSaint-Etienne, 42199, France
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.